Incorporated on March 2017, Accunea is a medical device business that is developing novel real-time point-of-care diagnostic and monitoring technologies for clinical transplant centres. Their premier product, RenoSure, is a bedside multi-parameter organ function monitoring device that provides unprecedented capabilities for monitoring organ function and metabolic condition both pre-and-post-transplantation.
Nick Housby and Dr Robert Learney have collaborated to build Accunea around the patent-pending RenoSure real-time organ function monitoring technology, initially developed by Dr Learney during his PhD research at Imperial College London.
Accunea Ltd. has raised funds to take the RenoSure device forward into clinical studies.
We are delighted to move into the Oxford BioEscalator as we start to grow our organisation and begin clinical studies. In this location, we will seek to engage with numerous academic, NHS and commercial entities.
Nick Housby - CEO